
Advanced Enzyme Technologies Ltd: Valuation Shifts Signal Heightened Price Risk
2026-11-20 08:00:40Advanced Enzyme Technologies Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. This change, coupled with its current price movements and relative performance against benchmarks, raises important questions about its price attractiveness and investment appeal in the Pharmaceuticals & Biotechnology sector.
Read More
Advanced Enzyme Technologies Ltd is Rated Sell
2026-11-13 10:11:34Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreAdvanced Enzyme Technologies Gains 6.56%: 4 Key Factors Driving the Week
2026-11-07 14:02:15Key Events This Week 2 Nov: Intraday high surge of 7.57% to Rs.283.60 2 Nov: Strong quarterly financial results reported 6 Nov: Technical momentum shifts to mildly bearish 6 Nov: Valuation reclassified as very expensive Week OpenRs.262.95 Week CloseRs.280.20<div class="stat-change positiv...
Read More
Advanced Enzyme Technologies Ltd Surges 7.57% to Day's High of Rs 283.6 — Outperforms Sector by 6.95 Percentage Points
2026-11-02 13:31:26The Sensex advanced 0.86% on 2 Nov 2026, yet Advanced Enzyme Technologies Ltd outpaced the broader market with a robust 7.57% gain, reaching an intraday peak of Rs 283.6. This 6.95 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read More
Advanced Enzyme Technologies Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend
2026-11-02 12:00:09Advanced Enzyme Technologies Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift from a previously flat trend. The company recorded its highest quarterly net sales and profitability metrics in recent history, reflecting robust operational execution within the Pharmaceuticals & Biotechnology sector.
Read More
Advanced Enzyme Technologies Ltd is Rated Sell
2026-11-02 10:10:25Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Advanced Enzyme Technologies Ltd is Rated Sell
2026-10-22 10:10:26Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 August 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 22 October 2026, providing investors with the latest perspective on the company’s position.
Read More
Advanced Enzyme Technologies Ltd Valuation Shifts Signal Elevated Price Risk
2026-10-15 08:00:51Advanced Enzyme Technologies Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite a modest 0.75% gain in its share price. This change reflects evolving market perceptions and valuation metrics in the Pharmaceuticals & Biotechnology sector, raising questions about price attractiveness relative to historical and peer benchmarks.
Read More
Advanced Enzyme Technologies Ltd is Rated Sell
2026-10-11 10:10:15Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 11 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Updates on Acquisition
19-Nov-2026 | Source : BSEUpdate on acquisition of additional stake of 1.22% in JC Biotech Private Limited Subsidiary i.e. increase in Shareholding from 95.72% to 96.94%
Corporate Action-Updates on Buy back
05-Nov-2026 | Source : BSEExtinguishment of 697582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity Shares of the face value of ? 2/- each (Rupees Two Only) of the Company from the Open Market through the Stock Exchanges
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
05-Nov-2026 | Source : BSEPlease find enclosed herewith transcript of earnings call held on November 03 2026 for unaudited financial results for the quarter and half year ended September 30 2026.
Corporate Actions
No Upcoming Board Meetings
Advanced Enzyme Technologies Ltd has declared 67% dividend, ex-date: 24 Jul 26
Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17
No Bonus history available
No Rights history available